Cargando…
The use of apatinib in treating primary pleural synovial sarcoma: A case report
RATIONALE: Apatinib is an oral tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2. It has been shown that apatinib is effective and safe for treatment of multiple solid tumors, including gastric cancer, liver cancer, non-small-cell lung cancer, and breast cancer. Howev...
Autores principales: | Chen, Sumei, Zhang, Ke, Wan, Xianqin, Chen, Yuanyuan, Ma, Shenglin, Deng, Qinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940042/ https://www.ncbi.nlm.nih.gov/pubmed/31861000 http://dx.doi.org/10.1097/MD.0000000000018382 |
Ejemplares similares
-
Primary renal synovial sarcoma: A case report
por: Zhang, Bei, et al.
Publicado: (2020) -
A case report of apatinib in treating osteosarcoma with pulmonary metastases
por: Zhou, Yong, et al.
Publicado: (2017) -
Treatment of limb synovial sarcoma with metastasis at presentation
por: Guo, Pan, et al.
Publicado: (2020) -
Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review
por: Cai, Sina, et al.
Publicado: (2017) -
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
por: Ding, Lin, et al.
Publicado: (2016)